Advertisement

Ads Placeholder
Loading...

Lumos Diagnostics Holdings Limited

LDX.AX•ASX
Healthcare
Medical - Diagnostics & Research
$0.21
$-0.02(-10.64%)
Australian Market opens in NaNh NaNm

Lumos Diagnostics Holdings Limited (LDX.AX) Stock Overview

Explore Lumos Diagnostics Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap167.5M
P/E Ratio-11.96
EPS (TTM)$-0.02
ROE-1.64%
Fundamental Analysis

AI Price Forecasts

1 Month$0.29
3 Months$0.34
1 Year Target$0.44

LDX.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lumos Diagnostics Holdings Limited (LDX.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.44.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.96 and a market capitalization of 167.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-10.64%
5-Day Change
-23.64%
1-Month Change
-28.81%
3-Month Change
-34.38%
6-Month Change
35.48%
Year-to-Date (YTD) Change
-34.38%
1-Year Change
775.00%
3-Year Change
728.90%
5-Year Change
-81.42%
All-Time (Max) Change
-81.42%

Contact Information

https://lumosdiagnostics.com
61 3 9087 1598
Level 4, Melbourne, VIC, 3205

Company Facts

IPO DateJul 5, 2021
CountryAU
Actively Trading

Frequently Asked Questions